Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.51
+0.06 (1.10%)
Aug 8, 2025, 4:00 PM - Market closed
Serina Therapeutics Employees
As of December 31, 2024, Serina Therapeutics had 13 total employees, including 12 full-time and 1 part-time employees. The number of employees increased by 2 or 18.18% compared to the previous year.
Employees
13
Change (1Y)
2
Growth (1Y)
18.18%
Revenue / Employee
$3,923
Profits / Employee
-$72,231
Market Cap
54.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 2 | 18.18% |
| Dec 31, 2023 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SER News
- 11 days ago - Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD) - GlobeNewsWire
- 12 days ago - Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference - GlobeNewsWire
- 4 weeks ago - Serina Therapeutics Makes Grant to New Employee Under Inducement Plan - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025 - GlobeNewsWire
- 7 weeks ago - UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42 - GlobeNewsWire
- 7 weeks ago - Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42 - GlobeNewsWire
- 2 months ago - Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?" - GlobeNewsWire